<?xml version="1.0" encoding="UTF-8"?>
<p id="p0155">Melatonin has several properties suggesting its utility in a variety of circumstances. It has high biological safety, and exogenous melatonin can be used in a variety of doses, even including extreme doses (
 <xref rid="bib5" ref-type="bibr">Andersen et al., 2016</xref>; 
 <xref rid="bib74" ref-type="bibr">Zhang et al., 2020a</xref>). It worth mentioning that a melatonin dose of 3–10 mg/day demonstrated acceptable safety level in clinical trials (
 <xref rid="bib15" ref-type="bibr">Chen et al., 2012</xref>; 
 <xref rid="bib54" ref-type="bibr">Othman et al., 2016</xref>; 
 <xref rid="bib61" ref-type="bibr">Seabra et al., 2000</xref>; 
 <xref rid="bib75" ref-type="bibr">Zhang et al., 2020b</xref>). Adverse events were generally minor, short-lived, and easily managed (
 <xref rid="bib26" ref-type="bibr">Foley and Steel, 2019</xref>). In addition to its high-safety profile, it can be administered through several routes. Melatonin constitutes a natural and easy-to-synthesize product that can be found over shelves with long half-time.
</p>
